In Vitro Fertilization Clinical Trial
Official title:
Luteal Phase Support With GnRH Agonist Alone After GnRH Agonist Triggering and Fresh Embryo Transfer Compared to the Reference Protocol (hCG Triggering and Progesterone Luteal Support): a Randomised Controlled Trial
The development of stimulation protocols for in vitro fertilisation (IVF) has led to a paradox. It has now been established that obtaining a large number of oocytes is a key to success, but that it is also a risk factor for embryo transfer failure after puncture (disruption of endometrial receptivity due to luteal insufficiency) and a risk factor for complications such as ovarian hyperstimulation syndrome (OHSS).
It is currently established that obtaining a large number of oocytes is a key of success in IVF/ICSI cycles. However, it is also a risk factor for ovarian hyperstimulation syndrome (OHSS) and a risk factor of implantation failure after fresh embryo transfer because of the alteration of endometrial receptivity. A freeze all strategy can be proposed to avoid these risks but vitrification of embryos, although more efficient than slow freezing in terms of embryo survival, is not without risk. Furthermore, proper endometrial and embryo timing for frozen-thawed embryo transfer is still debated. Recent preliminary works suggest another possible way to combine an optimal ovarian response with the recovery of a large number of oocytes, good chances of implantation and a reduced risk of OHSS. To achieve this goal, ovulation triggering and luteal phase support need to be modified together. The human chorionic gonadotropin (hCG) (mimicking the Luteinising Hormone (LH)peak to trigger ovulation) that induces OHSS is replaced by an a GnRH agonist (GnRHa) triggering allowing an endogenous peak of Follicle Stimulating Hormone (FSH) and LH. Then, the usual support of the luteal phase by exogenous vaginal progesterone, whose absorption seems to be suboptimal for about 30% of patients, is replaced by endogenous progesterone production by the corpora lutea, supported by the maintenance of LH activity through the continuation of agonist of gonadotropin releasing hormone (AgoGnRH) in the luteal phase. Pilot studies show that a 10% to 15% increase in ongoing pregnancy rates can be expected with this type of protocol. The objective of our study is to demonstrate an increase in ongoing pregnancy rate per cycle with this new strategy combining GnRHa triggering and GnRHa luteal phase support compared to the reference protocol (hCG triggering and exogenous progesterone luteal phase support). ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00696878 -
Corifollitropin Alfa in Participants Undergoing Repeated Controlled Ovarian Stimulation (COS) Cycles Using a Multiple Dose Gonadatropin Releasing Hormone (GnRH) Antagonist Protocol (Study 38825)(P05714)
|
Phase 3 | |
Recruiting |
NCT04122729 -
N680S Polymorphism of the FSHR Gene and Its Relationship With the Type of Gonadotropin Used in COS
|
||
Not yet recruiting |
NCT02534857 -
A Study Comparing a Shorter Exposure of Oocyte to Spermatozoa Versus a Standard Incubation on the Live Birth Rate of In-vitro Fertilization Treatment
|
N/A | |
Recruiting |
NCT01406600 -
Optimal rhCG(Ovidrel®) Dose in Poor Responder During IVF and ICSI Cycles
|
N/A | |
Completed |
NCT01406028 -
Does Emotional Support Decrease In Vitro Fertilization Stress?
|
N/A | |
Withdrawn |
NCT00541892 -
Sibling Oocyte Study of Medium for In Vitro Fertilization/Intracytoplasmic Sperm Injection (IVF/ICSI) With no Human Serum Albumine
|
Phase 2 | |
Completed |
NCT00708383 -
in Vitro Fertilization (IVF) Media Protein and Live Birth Rates
|
N/A | |
Completed |
NCT03627533 -
The Differences of Oocyte Maturation, Granulosa Cell Apoptosis Index Between Electroacupuncture And Sham Groups IVF
|
N/A | |
Recruiting |
NCT04160611 -
What Amount of Stress is Enough for a Successful Conception?
|
Phase 3 | |
Suspended |
NCT01600794 -
To Evaluate The Anrogens and Ovary Function in In Vitro Fertilization
|
N/A | |
Completed |
NCT01507376 -
Comparing the Efficacy of Urinary and Recombinant Human Chorionic Gonadotropin (hCG) on Oocyte Maturity
|
Phase 3 | |
Terminated |
NCT00866008 -
A Study of the Effects of a Novel Ovarian Stimulation Regimen on Embryo Aneuploidy Rates in In Vitro Fertilization (IVF)
|
Phase 4 | |
Recruiting |
NCT04082650 -
Vitamin D and Pregnancy Outcome in PCOS Patients
|
N/A | |
Recruiting |
NCT03758833 -
eSET or eDET Associated to PGT in IVF
|
N/A | |
Not yet recruiting |
NCT04407871 -
Acupuncture and Chinese Herbal Medicine to Improve Live Birth Rate of in Vitro Fertilization (IVFAct)
|
N/A | |
Recruiting |
NCT03345030 -
The Role of DNA Damage of Granulosa Cell on Oocyte Quality and in Vitro Fertilization Outcome
|
N/A | |
Not yet recruiting |
NCT06367985 -
CAPA-IVM Culture With Low Oxygen Tension
|
N/A | |
Not yet recruiting |
NCT03090438 -
IVF Outcomes After Varicocele Repair
|
N/A | |
Terminated |
NCT01614067 -
Delayed Start to Ovarian Stimulation
|
Phase 4 | |
Completed |
NCT01343992 -
Bed Rest or no Bed Rest?
|
N/A |